XML 30 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Share Based Awards
12 Months Ended
Apr. 30, 2021
Share-based Payment Arrangement [Abstract]  
Share Based Awards

Note 12 - Share Based Awards

 

Effective August 2019, shareholders approved the 2019 Equity Incentive Plan (the “Plan”) which allows us to incentivize key employees, consultants, and directors with long term compensation awards such as stock options, restricted stock, and restricted stock units (collectively, the “Awards”). The number of shares issuable in connection with Awards under the Plan may not exceed 8,750,000.

 

Options exercisable as of April 30, 2021 totaled 1,305,810. The remaining weighted average contractual term of the options outstanding at April 30, 2021 was 8.68 years. The aggregate intrinsic value of outstanding options, representing the excess of the stock price at April 30, 2021 of $4.04 over the exercise price of each option, was $4,943,870. As of April 30, 2021 and 2020, there was $914,915 and $1,009,731 of unrecognized stock-based compensation expense related to unvested stock options, net of estimated forfeitures, which is expected to be recognized over the weighted average period of 1.08 years.

 

The table below sets forth the assumptions used on the date of grant for estimating the fair value of options granted during the years ended April 30, 2020 and April 30, 2021:  

 

   2021  2020
Exercise price   2.01 - 3.95    0.82 - 2.10 
Stock price on date of grant   2.01 - 3.95    0.82 - 2.10 
Volatility   88.60% - 91.44%   75%
Risk-free interest rate   0.38% - 1.66%   1.59 - 1.74%
Expected term (years)   5.87 - 10.00    5.00 - 10.00 
Dividend yield   —      —   

 

A summary of activity under the Plan for the two years ended April 30, 2021 is as follows:

 

Options  Shares  Weighted-Average Exercise Price  Weighted-Average Remaining Contractual Term  Aggregate Intrinsic Value
                     
Outstanding as of April 30, 2019   —      —             
Granted   1,597,475   $1.10           
Exercised   —      —             
Forfeited or expired   —      —             
Outstanding as of April 30, 2020   1,597,475    1.10           
Granted   600,000    3.63           
Exercised   —      —             
Forfeited or expired   —      —             
Outstanding as of April 30, 2021   2,197,475   $1.79    8.68   $4,943,870 
Exercisable as of April 30, 2021   1,305,810   $2.21    9.00   $2,388,208 

 

Stock compensation expense for the years ended April 30, 2021 and 2020 was as follows:

  

   2021  2020
General and administrative  $1,688,025   $213,959 
Research and development   1,269,987    55,936 
Operations   220,048    —   
Sales and marketing   210,156    —   
 Total  $3,388,216   $269,895